WHO Reverses Decision to Stop Hydroxychloroquine COVID-19 Trial The World Health Organization announced Wednesday that it is resuming a global trial of the malaria drug hydroxychloroquine as a potential COVID-19 treatment, which it suspended last week after a leading medical journal published a study raising concerns about its safety and efficacy.
Hydroxychloroquine (HCQ) is the drug which President Trump told reporters on May 18 he was taking as a coronavirus preventive measure, attracting criticism and ridicule from media commentators, late-night television hosts, and some Democrats.
The WHO reversal came after its “data safety and monitoring committee†found no reason not to continue the HCQ clinical trial, “on the basis of the available mortality data,†Director-General Tedros Adhanom told a briefing in Geneva.
The medical journal concerned, meanwhile, issued an “expression of concern†about the quality of the study it published earlier.
The Lancet said that pending the outcome of “an independent audit of the provenance and validity of the data†now underway, “we are issuing an Expression of Concern to alert readers to the fact that serious scientific questions have been brought to our attention. We will update this notice as soon as we have further information.â€..............
https://www.cnsnews.com/article/international/patrick-goodenough/who-reverses-decision-stop-hydroxychloroquine-covid-19
